(616 Kb) Site

This article, available through PubMed Central (PMC) , provides a comprehensive look at how the drug performs in real-world clinical settings compared to controlled trials. Study Overview: The 616-Patient Cohort

: For those who stopped the medication, the median time until they did so was only 7 months . (616 KB)

: Interestingly, the most common reason for stopping the drug was toxicity (intolerance) rather than the leukemia getting worse (disease progression). This article, available through PubMed Central (PMC) ,